Capital Market Strategies’s Pfizer PFE Stock Holding History

Capital Market Strategies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,755	Closed	-$243K	–	155
2024 Q1	$243K	Sell	8,755 -3,451	-28%	-$95.8K	0.19%	121
2023 Q4	$351K	Sell	12,206 -6,785	-36%	-$205K	0.31%	77
2023 Q3	$644K	Sell	18,991 -1,542	-8%	-$54.5K	0.64%	35
2023 Q2	$753K	Sell	20,533 -2,294	-10%	-$89.3K	0.7%	33
2023 Q1	$931K	Sell	22,827 -3,181	-12%	-$137K	1.65%	16
2022 Q4	$1.33M	Buy	26,008 +186	+0.7%	+$8.92K	1.43%	14
2022 Q3	$1.13M	Sell	25,822 -402	-2%	-$19.5K	1.27%	17
2022 Q2	$1.38M	Buy	26,224 +39	+0.1%	+$1.99K	1.44%	15
2022 Q1	$1.36M	Sell	26,185 -1,758	-6%	-$91.2K	1.17%	18
2021 Q4	$1.65M	Buy	+27,943	New	+$1.38M	1.36%	13

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Market Strategies's PFE Position: Q2 2024 in Review

Capital Market Strategies sold out of Pfizer (PFE) in Q2 2024, closing a stake of 8,755 shares — an estimated $243K sold.

Capital Market Strategies first reported a position in PFE in Q4 2021 and held it in 10 quarters. The position peaked at $1.65M in Q4 2021. 2,879 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Capital Market Strategies reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
Capital Market Strategies sold 8,755 Pfizer shares in Q2 2024, an estimated $243K.
Capital Market Strategies first reported a position in Pfizer in Q4 2021 and held it in 10 quarters.
Capital Market Strategies's Pfizer position peaked at $1.65M in Q4 2021.
2,879 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Capital Market Strategies's 13F filing for Q2 2024, filed 1 Jul 2024.